TWST Form 144: Insider Plans Sale of 238 Shares Valued $6,179

Form 144 notice from Twist Bioscience (TWST) shows an insider sale filing for common stock.

Rhea-AI Filing Summary

Form 144 notice from Twist Bioscience (TWST) shows an insider sale filing for common stock. The filer plans to sell 238 shares via Fidelity Brokerage Services on NASDAQ with an aggregate market value of $6,179.48 and an approximate sale date of 08/21/2025. The shares were acquired on 08/20/2025 through restricted stock vesting and were received as compensation. The filing lists four prior small common-stock sales by Robert Werner totaling 1,492 shares between 05/21/2025 and 08/04/2025 with gross proceeds reported for each sale. The notice includes the standard certification that the signer is unaware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small, routine insider sale from recently vested restricted stock; no material red flags in the filing.

The filing documents a proposed sale of 238 shares valued at $6,179.48 by an insider through Fidelity on NASDAQ, with acquisition dated 08/20/2025 via restricted stock vesting and payment characterized as compensation. Historical disposals by the same person total 1,492 shares across four trades earlier in 2025, with gross proceeds reported per trade. The sizes and timing suggest routine monetization of vested compensation rather than large-scale divestiture. The filing contains the standard attestation regarding knowledge of material nonpublic information.

Corporate Governance Expert

TL;DR: Disclosure is complete for Rule 144 purposes; documentation shows compensation-related vesting followed by planned sales.

The Form 144 provides required elements: number of shares, acquisition date and nature (restricted stock vesting), broker details, planned sale date, and prior sales in the past three months. All listed transactions are relatively small in absolute terms and tied to compensation. The signature/attestation language is present. The filing does not disclose any material adverse facts or trading-plan adoption dates.

FAQ

What does the TWST Form 144 filed for 08/21/2025 disclose?

It discloses a proposed sale of 238 common shares valued at $6,179.48 through Fidelity on NASDAQ, acquired 08/20/2025 via restricted stock vesting.

Who acquired the securities being sold according to the filing?

The securities were acquired from the issuer on 08/20/2025 as restricted stock vesting and were paid as compensation.

Has the seller made other sales of TWST stock recently?

Yes. The filing lists four prior sales by Robert Werner on 05/21/2025, 05/23/2025, 06/06/2025, and 08/04/2025 totaling 1,492 shares with reported gross proceeds per trade.

What broker will execute the planned sale in the Form 144?

Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI 02917) is named as the broker for the 238-share sale.

Does the filing indicate any undisclosed material information about the company?

No. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2025 - 03:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001590947
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	WERNER ROBERT F.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	238	6179.48	60360925	08/21/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Restricted Stock Vesting	Issuer			238	08/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Werner 681 Gateway Blvd South San Francisco CA 94080	Common	05/21/2025	242	7198.87
Robert Werner 681 Gateway Blvd South San Francisco CA 94080	Common	05/23/2025	839	23263.88
Robert Werner 681 Gateway Blvd South San Francisco CA 94080	Common	06/06/2025	225	7143.66
Robert Werner 681 Gateway Blvd South San Francisco CA 94080	Common	08/04/2025	186	5275.72

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert F. Werner.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)